Skip to content

Author

Özgür Yılmaz

We have 4 of 26 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Beyond Tumor Accumulation in Oncology Peptide Drug Conjugates: A Critical Narrative Review of Release-Competent Exposure and a Stage-Gated Translational Roadmap

Peptide–drug conjugates (PDCs) combine peptide-mediated targeting or transport with a pharmacologically active payload. This critical narrative review organizes oncology PDC development around release-competent exposure (RCE): the connection between conjugate integrity, formation of an identified active compound, deliv...

Ahmet Akif Kızılkurtlu, Fatih Ciftci, Özgür Yılmaz · 0 citations
Open access Aug 2026

Organotin-Catalyzed Synthesis, Characterization, Anticancer and Antioxidant Activities, and Molecular Modeling Studies of Nimesulide Ureas as Potential MetAP (Type II) Inhibitors

In silico results and in vitro studies suggest that the nimesulide derivatives may be novel, potential NSAID-based anticancer drug candidates for treating breast, prostate, gastric, and glioblastoma.

Yağmur Biliz, Özgür Yılmaz, Elif Kuloğlu et al. · 0 citations
Jul 2026

Development of Eudragit L100/sodium alginate-carrageenan core/shell nanofiber patches for dermal delivery of omega-3 acid ethyl ester.

Overall, EL100/SA-CRG core-shell nanofibers provide a dry, handleable, and biologically tolerated platform for sustained topical delivery of labile omega-3 ethyl esters, thereby supporting their further development as advanced dermal patches for skin repair and dermocosmetic applications.

Merve Karataş, Kubra Aranci, Ahmet Akif Kızılkurtlu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.